Nebivolol Hydrochloride Amarox

Nebivolol Hydrochloride, the active ingredient in Nebivolol Hydrochloride Amarox, is a beta‑adrenergic blocker presented as an oral tablet for oral use. It treats hypertension in adult patients by lowering elevated blood pressure.

GNH USA supplies Nebivolol Hydrochloride Amarox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebivolol Hydrochloride is a selective β1‑blocker used in the management of high‑blood‑pressure disorders.

- Primary hypertension: reduces systolic and diastolic pressure in patients with essential hypertension. - Essential hypertension: provides long‑term blood‑pressure control in adults. - Isolated systolic hypertension: helps lower elevated systolic readings in elderly patients.

Nebivolol Hydrochloride may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild to moderate intensity. - Dizziness: often related to blood‑pressure lowering. - Fatigue: general tiredness or reduced energy. - Nausea: occasional stomach upset. - Bradycardia: slower than normal heart rate. - Peripheral edema: mild swelling of ankles or feet.

Serious or Rare Side Effects: - Severe bradycardia: markedly low heart rate requiring medical attention. - Symptomatic hypotension: sudden drop in blood pressure causing faintness. - Allergic reaction: rash, itching, or swelling of face and throat. - Hepatic injury: abnormal liver function tests. - Heart block: impaired electrical conduction in the heart. - Acute bronchospasm: difficulty breathing, especially in asthmatic patients.

Before initiating therapy, clinicians should consider several safety factors.

- Renal impairment: monitor kidney function and adjust therapy as needed. - Asthma or chronic obstructive pulmonary disease: use with caution as β‑blockade may worsen bronchospasm. - Diabetes mellitus: may mask hypoglycaemia symptoms; monitor blood glucose closely. - Concomitant use of other antihypertensives: risk of additive blood‑pressure lowering. - Pregnancy: safety not established; avoid unless benefits outweigh risks. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Nebivolol Hydrochloride can interact with several drug classes, influencing its safety profile.

Major Interactions (Avoid): - Non‑selective beta‑blockers: additive bradycardia and hypotension. - Calcium‑channel blockers (verapamil, diltiazem): increased risk of AV‑block. - Clonidine: abrupt discontinuation may cause rebound hypertension.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may enhance hypotensive effect. - Diuretics: can increase risk of electrolyte disturbances. - SSRIs or other antidepressants: may affect heart‑rate regulation.